丹麦国家乳腺癌筛查项目中两种乳腺X线影像采集模式筛查性能指标与患者剂量比较
该研究回顾性分析丹麦南部地区72,188例筛查病例,比较无滤线栅PRIME模式与有滤线栅模式的筛查性能与剂量。无滤线栅模式特异度98.11%(95%CI 97.93%-98.29%),有滤线栅模式97.96%(95%CI 97.84%-98.09%),癌检出率均为0.55%。无滤线栅模式平均腺体剂量较有滤线栅模式降低13.5%-36.4%(取决于乳腺厚度)。
要点
- 无滤线栅模式与有滤线栅模式癌检出率均为0.55%,等效性界值0.12个百分点。
- 无滤线栅模式特异度98.11%(95%CI 97.93%-98.29%),有滤线栅模式97.96%(95%CI 97.84%-98.09%)。
- 无滤线栅模式平均腺体剂量较有滤线栅模式降低13.5%-36.4%,取决于乳腺厚度。
核心结论
- 无滤线栅联合软件散射校正采集在乳腺X线摄影中可作为有滤线栅采集的替代方案,筛查性能等效且患者剂量明显降低。
研究设计与样本
- 回顾性分析丹麦南部地区同一地理区域72,188例筛查病例,分为无滤线栅采集模式安装前与安装后两个研究人群;使用MAMMOMAT Inspiration系统,无滤线栅模式(PRIME)采用软件散射校正替代滤线栅。
诊断标准与关键数值
- 无滤线栅模式特异度98.11%(95%CI 97.93%-98.29%),有滤线栅模式特异度97.96%(95%CI 97.84%-98.09%);癌检出率作为敏感度指标两组均为0.55%;癌检出率等效性界值0.12个百分点,特异度等效性界值0.40个百分点。
临床应用与阅片要点
- 无滤线栅采集模式在有软件散射校正条件下可替代有滤线栅采集用于乳腺癌筛查,平均腺体剂量降低13.5%-36.4%(取决于乳腺厚度)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: In this study, screening performance metrics and radiation dose were compared for two image acquisition modes for breast cancer screening with MAMMOMAT Inspiration (Siemens Healthcare GmbH, Forchheim, Germany). This mammography system can operate without an anti-scatter grid in place but using software scatter correction instead. This grid-less acquisition mode (PRIME) requires less patient dose due to the increase in primary radiation reaching the detector. This study retrospectively analyses data from the Region of Southern Denmark where the grid-less mode has been installed in November 2013 and replaced grid-based screening.
METHODS AND MATERIALS: A total of 72,188 screening cases from the same geographical region in Denmark were included in the study. They were subdivided into two study populations: cases acquired before and after installation of the grid-less acquisition mode. Sensitivity and specificity of breast cancer screening were calculated for the two populations; thus representing the performance of grid-less and grid-based screening. To measure the entrance surface air kerma (ESAK) additional phantom tests were carried out. Polymethylmethacrylate (PMMA) attenuation plates with different thicknesses (20-70 mm in steps of 10 mm) simulated the compressed breast (21 mm-90 mm) and a solid-state dosimeter was used.
RESULTS: Statistical testing of the results showed that screening with grid-less acquisition provides equivalent performance with respect to sensitivity and specificity compared to grid-based screening. The specificity was 98.11% (95% confidence interval (CI) from 97.93% to 98.29%) and 97.96% (95% CI from 97.84% to 98.09%) for screening with grid-less acquisition and grid-based acquisition, respectively. The cancer detection rate as a measure for sensitivity was equal (0.55%) for grid-less screening and grid-based screening. An average glandular dose saving between 13.5% and 36.4% depending on breast thickness in grid-less acquisition was obtained compared to grid-based acquisition.
CONCLUSION: Statistically significant equivalence was shown with an equivalence margin of 0.12% points for cancer detection rate and with an equivalence margin of 0.40% points for specificity. A marked patient dose savings in grid-less acquisition of up to 36% compared to grid-based acquisition was achieved. It can be concluded that grid-less acquisition with software scatter correction is an alternative to grid-based acquisition in mammography.
引用
- Abdi AJ, Fieselmann A, Pfaff H, et al. Comparison of screening performance metrics and patient dose of two mammographic image acquisition modes in the Danish National Breast Cancer Screening Programme. Eur J Radiol. 2018. PMID: 30017278. doi:10.1016/j.ejrad.2018.06.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。